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The Eosinophil-Specific Cell Surface Antigen, EOS47, Is a Chicken Homologue of the Oncofetal Antigen Melanotransferrin
By Kelly M. McNagny, Fabio Rossi, Graham Smith, and Thomas Graf The EOS47 antigen is a 100-kD cell sutface glycoprotein selectively expressed by avian retrovirus-transformed eosinophils and their precursors. We have purified the EOS47 protein t o homogeneity and used peptide sequence information t o clone EOS47-encoding cDNAs. The open reading frames from these cDNAs predict a 738 amino acid protein with homology t o human melanotransferrin, a membrane-bound, transferrin-like protein that is expressed at high levels by a subset of melanomas, tumor cell lines, fetal intestine, and liver, but not by most normal adult tissues. The predicted protein sequence of EOS47 displays a 61% sequence identity with melanotransferrin and conservation of all 28 cysteine residues, indicating a similar tertiary structure. The finding that EOS47 lacks several of the iron-coordinating amino acids present in all transferrins suggests that it may be impaired in its ability t o bind iron. In nonhematopoietic tissues,
OSINOPHILS ARE ONE OF three distinct subpopulations of polymorphonuclear granulocytes produced in vertebrate bone
Although they comprise a minor subpopulation of the peripheral blood leukocytes (approximately 2% to 5%), they are rapidly recruited to sites of hypersensitivity (particularly in bronchial asthma) and to sites of parasitic (helminths) infections. The primary immunologic role of eosinophils appears to be the destruction of multicellular parasites by degranulation and release of a number of toxic, granule proteins including major basic protein, eosinophil cationic protein, eosinophil derived neurotoxin, and eosinophil per~xidase.~ In chronic bronchial asthma, eosinophils play a major role in inflammation and pathologic respiratory cell damage by the release of this same complement of granular protein^.^.^ Several cytokines are known to promote the production of eosinophils from bone marrow hematopoietic precursors. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) enhance the production of eosinophils and precursors for several other hematopoietic lineages, whereas IL-5 exclusively promotes the production and terminal differentiation of eosinophil^.^^^ Colony-forming assays in the presence of mixtures of these cytokines have suggested that eosinophil precursors represent a heterogeneous pool of cells that vary in their cytokine requiremenk6 However, relatively little is known about the early stages of eosinophil differentiation, largely due to the lack of lineage-specific surface markers that would allow the isolation and characterization of normal precursors and due to the limited number of differentiation-inducible eosinophilic cell lines.'" ' We reported previously the ability of the myb-ets-containing avian retrovirus E26 to transform cells with the properties of multipotent hematopoietic precursors (referred to as MEPs for Myb-Ijts ~r o g e n i t o r~'~~~~) .
These transformants spontaneously differentiate into erythrocytes and thrombocytes and can be efficiently induced to differentiate into either myeloblasts or eosinophils by treatment with phorbol esters or by over-expression of kinase type oncogenes.'*J3 Using this in vitro differentiation system, we have generated a panel of monoclonal antibodies (MoAbs) specific for E26- EOS47 is expressed at high levels by epithelial brush borders of small intestine and kidney and at lower levels by cells lining the sinusoids of the liver. Within hematopoietic tissues, EOS47 is restricted t o a subpopulation of cells (1% t o 5%) in bone marrow and early spleen and fluorescenceactivated cell sorting of EOS47+ cells leads t o a dramatic (>JO-fold) enrichment of peroxidase+ eosinophils. In contrast, peripheral blood eosinophils are EOS47-, suggesting that the antigen is expressed by newly formed eosinophils and that expression ceases shortly before these cells emigrate from the bone marrow into the peripheral blood. Our results show that melanotransferrin is a stage-specific marker of eosinophils and should be useful for their isolation and further characterization. 0 1996 by The American Society of Hematology.
transformed progenitors, myeloblasts, and eosinophils." One antibody, named EOS47, specifically reacts with peroxidase' eosinophils (an enzyme that in avian hematopoietic cells is expressed exclusively by eo~inophilsl~"~) and their precursors, but not by transformed cells of other hematopoietic lineage^.^',^^ We report here the cloning and sequencing of several EOS47 encoding cDNAs. The predicted protein sequence shows a high degree of homology with human melanotransfemn, a transferrin-like molecule expressed selectively by melanomas and other nonhematopoietic tumor cell lines. Analysis of antigen expression by normal hematopoietic cells suggests that melanotransferrin may become a valuable lineage and maturation stage-specific marker of eosinophils.
MATERIALS AND METHODS
Animals, primary tissues, and cells. All primary tissues and cells were derived from commercially produced Valo eggs and birds which were maintained at the EMBL animal care facility.
Cell lines and culture conditions. The origins of the cell lines used as sources of RNA have been described previously: HD3 erythroblasts"; HD44 erythroblasts"; HDl1 macrophages (described earlier as LSCC-MCMAl)"; HD13
HD57
multipotent cells"; HD57M myelobla~tsl~; HD5OM-GATA-l + eosinophils"; MSB-I T cellsz3; and RP-l2 B cell^.'^ To generate the HDlOO cell line, 2-day-old chicken blastoderms were infected with the E26 virus and plated in semisolid medium as described previously.13 Transformed colonies were pooled and serially passaged for 6 months to select for continuously proliferating cell lines. Screening subclones of these cell lines by surface immunofluorescence led to the identification of one clone that constitutively expresses the EOS47 All cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, 2.5% chicken serum, 0.15% NaHC03, 56 pg/mL of conalbumin, 80 mmol/L 2-mercaptoethanol, 0.9 pg/mL insulin, and the standard complement of antibiotics at 37°C in 5% CO,. Medium for HDSOM and HDl1 cells was supplemented with chicken myelomonocytic growth facProtein puri'cation and sequencing. Proteins from approximately 1010 HDl00 cells were solubilized in 50 mL of lysis buffer (150 mmol/L NaCI, 50 mmol/L Tris [pH 7.51, 0.5% NP-40) plus protease inhibitors (1 mmol/L phenylmethylsulfonylfluoride [PMSF], 20 rnmoVL e-amino-n-caproic acid, 1 mg/mL leupeptin, and 2.5 U/mL trasylol) on ice for 30 minutes. Nuclei were removed by centrifugation at 15,OOOg for 30 minutes at 4"C, and the supernatant was incubated overnight at 4°C with 200 pL of EOS47 antibodycoupled Sepharose beads (4 mg of antibody coupled per milliliter of CNBr-activated Sepharose resin; Pharmacia, Uppsala, Sweden). Beads were washed 10 times with 2 mL of lysis buffer containing protease inhibitors and once with phosphate-buffered saline (PBS) plus PMSF, and bound proteins were eluted in 0.1 % trifluoroacetic acid plus PMSF. Eluted fractions were equilibrated to neutral pH by the addition of Tris buffer, lyophilised, resuspended in sample buffer, and resolved on a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel. Resolved proteins were blotted onto Immobilon-P filters (Millipore, Bedford, MA) using CAPS buffer (10 mmol/L 3-[cyclohexylamino]-l-propanesulfonic acid [pH lo], 10% methanol), and the filters were stained with 0.1% Coomassie Blue R-250 in 40% methanol/lO% acetic acid and destained in 50% methanol. Filter strips containing EOS47 protein were digested with trypsin, fragments were separated by reversephase high-performance liquid chromatography (HPLC; Applied Biosystems model 170A; Applied Biosystems, Foster City, CA), and individual peptides were sequenced by automated Edman degradation using an Applied Biosystems sequencer (model 477A) connected to an online phenyl thiohydantoin analyzer (Applied Biosysterns model 120). Two peptides with the highest homology to human melanotransfenin, EOSTRIS-41 and EOSTRIS-42, were used for degenerate oligonucleotide primer synthesis.
Sequence comparisons were performed using FASTA searches of the Genembl and Swissprot databases. Evolutionary trees were derived using the Clustal V software and Pileup alignments of sequences retrieved from the Swissprot database. FASTA and Pileup are part of the Wisconsin package Version 8.0 (Genetics Computer Group Inc, Madison, WI). Clustal V software is publicly available through the EMBL FI'P site (ftp.embl-heidelbergde).
Polymerase chain reaction (PCR) and library construction. Degenerate, PCR primers were designed based on the sense sequence for the EOSTRIS-41 peptide (5'-GCIGTIGTIGTIMGICCIGAY-ACIGAYAAYACIGCIGTI'lTYCAM-3') and the antisense sequence for the EOSTRIS-42 peptide (5'-TCICCICCIGCIGGIACN-AGNCCRTA-3'). Poly(A)+ RNA was prepared from HDlOO total RNA (see below) using oligo(dT)-celluloseZx and then converted to single-stranded cDNA using a IZAP-cDNA synthesis kit (Strategene, La Jolla, CA) according to the manufacturer's instructions. PCR of single-stranded cDNA was performed using Taq polymerase (Pharmacia) and buffer conditions recommended by the manufacturer. Amplification was performed by 30 cycles of 30 seconds of denaturation at 95"C, 30 seconds of template annealing at 40°C and 90 t~r .~~.~~ seconds of elongation at 72°C. using an "Intelligent Heating Block" (Biometra, Goettingen, Germany). PCR products were cloned into plasmids using a TA cloning kit (InVitrogen, San Diego, CA) and transformed into Escherichia coli strain XI-l blue, and 2 positive clones were identified by restriction map andor sequence analysis of 20 recombinants.
An HDlOO cDNA phagemid library was constructed from 5 pg poly(A)+ RNA using a XZAP-cDNA synthesis kit (Strategene) according to the manufacturer's instructions and was packaged into viable phage using Gigapack Gold I1 (Strategene) packaging extracts. One million recombinant phage from the unamplified library were plated on XL-l MW' bacterial host strain and these were screened by hybridization with a "P-labeled EOS47 PCR fragment probe" (see below). Ten recombinants were identified and plaquepurified by two further rescreens, and plasmids were produced by in vivo excision using the protocols recommended by the AZAPcDNA synthesis kit manufacturer (Strategene). Inserts were sequenced by the EMBL DNA sequencing service using an EMBL automated sequencer or its commercial counterpart (A.L.F. DNA sequencer; Pharmacia).
Nucleic acid hybridization.
For Northern blot analysis, total RNA was prepared by lysis and fractionation in guanidinium/acetate/ phenolkhloroform as described by Chomczynski and Sacchi." Approximately 10 pg of each RNA was resolved on a 1% agaroseformaldehyde gel and blotted onto nylon membranes (Genescreen; Dupont, Newtown, CT) as described by Sambrook et al.'* Hybridization of radiolabeled probes and removal of unbound probe was performed in NaHPOJSDS buffer, as described previou~ly.~~ All hybridization probes were labeled with [a-"P] dCTP by random hexamer priming as described by Feinberg and Volgelstein.'" The following cDNA fragments were used as probes: a 0.45-kb PCR fragment of EOS47 (see above); a 1.5-kb Pst I fragment of EOS47 type 1, 2, and 3 clones; a 0.45-kb 3' Sac I fragment specific for EOS47 type 2 clones; a 0.3-kb 3' Spe I fragment specific for EOS47 type I clones; and a GAPDH-specific probe."
Immunohistologic analysis, immunojuorescence, and peroxidase staining. Dissected tissues were imbedded in Tissue-Tek (Miles), snap frozen in liquid NZ. and stored at -80°C. Frozen sections (4 pm) were cut using a -20°C microtome, fixed on glass slides for 5 minutes in acetone, and dried at -20°C. The tissues were covered for 20 minutes with 100 mL of 10% calf serum in PBS and then stained with 100 mL MoAb followed by biotinylated goat antibodies to mouse IgG. Tissues were incubated for 30 minutes at room temperature, washed three times with PBS, and then soaked 20 minutes in methanol containing 0.3% H2OZ to block endogenous peroxidases. The methanol-treated sections were washed with PBS, incubated for 30 minutes with 1 0 mL of avidin-biotin peroxidase complex reagent (Vector Labs, Burlingame, CA), and exposed to 0.5 mg/mL of 3,3'-diaminobenzidine substrate (Sigma, St Louis, MO) in PBS containing 0.03% H202. After developing for IO minutes, the sections were washed with PBS, counterstained with 1% methyl green, washed briefly in H20, dehydrated in graded alcohols, and mounted for microscopic analysis.
For PI-PLC digests and indirect immunofluorescence analysis, 1 x lo6 cells were washed twice in PBS and resuspended in 500 mL of Hanks' balanced salt solution (HBSS; GIBCO, Life Technologies, Petersburg, MD) containing 2 mmol/L HEPES (pH 7.4) in the presence or absence of 0.35 U of PI-PLC (Sigma). Cells were washed 2 times in PBS and stained with EOS47," MEP17 (anti-VLA-2)""" or MYL51/2" MoAbs or with normal mouse serum, as described previously.'3 All flow cytometric analyses were performed using a Becton Dickinson FACScan (Becton Dickinson, Franklin Lakes, NJ). Cell sorting was performed using Facstar Plus (Becton Dickinson) and Epics Coherent (Coulter, Hialeah, E) cytometers.
Eosinophil peroxidase staining was performed by modification of use only.
For personal at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From the procedure described by K a p l o~?~ which allows the analysis of peroxidase expression in viable cell^.'^ Myeloperoxidase activity has not been detected in several detailed studies of avian granulocytes and granular peroxidase has proven to be an exclusive marker of the eosinophil lineage in chickens.""
RESULTS
Production of the HDlOO cell line, purijication of the EOS47 protein, and peptide sequencing. Pools of primary E26-transformed progenitor clones were serially passaged until cell lines were established and subcloned (see Materials and Methods and Metz and Graf"). One of these cell lines, named HD100, expresses several phenotypic markers characteristic of E26-transformed progenitor lines, but is unusual in that it also expresses high levels of the EOS47 antigen and, unlike most E26-transformed progenitor lines, fails to differentiate on treatment with TPA'2~13*20 (unpublished observations). This cell line was used as a source of EOS47 protein. For this purpose, proteins from approximately 1 X 10" HDlOO cells were solubilized by detergent lysis and EOS47 was purified to homogeneity by immunoaffinity chromatography followed by preparative gel electrophoresis and electroblotting. Purified EOS47 was then digested with trypsin, and peptides were separated by reverse-phase HPLC and sequenced.
A FASTA search of the Swissprot data base with the resulting peptide sequences showed three with greater than 58% sequence identity to human rnelanotran~ferrin."*~~ Based on the sequence of two peptides, EOSTRIS-41 and EOSTRIS-42, degenerate oligonucleotides were synthesized and used to PCR amplify and subclone a 453-bp cDNA probe (see Materials and Methods). This probe was used to screen an HDlOO cDNA library cloned in a AZap bacteriophage vector. Ten positive clones were identified and subcloned from 1 X lo6 recombinants in an unamplified HDlOO library. Based on restriction mapping and sequencing of 5' and 3' termini, these clones can be separated into three categories (Fig 1A) . Type 1 clones (8 clones) display identical restriction maps and 3' untranslated regions and vary only in the length of their 5' termini (probably due to heterogeneous stopping of reverse transcriptase during cDNA synthesis). The longest of these clones (2,802 bp) was sequenced and found to contain a predicted 5' untranslated region of 172 bp followed by an open reading frame of 2,214 bp and a 3' untranslated region of 404 bp (Fig 1A and B , and data base access no. X91908). The end of this 3' untranslated region contains an imperfect polyadenylation signal sequence AT-TAAA (consensus AATAAA) followed 18 bp later by a poly(A) tail. The second type of cDNA clone (1 clone) has an alternative 3' tail that begins within the last 5 1 bp of the coding region and ends with the poly(A) tail (Fig 1A and  C) . The 3' untranslated region of this clone contains two perfect polyadenylation signals 13 and 31 bp upstream of the poly(A) tail. These alternative 3' termini should result in a different coding sequence at the carboxy-terminus of the protein (Fig 1C and see below) . The third type of cDNA (one clone) is identical to the type 1 cDNAs throughout its sequence up to the polyadenylation site but then contains a unique 72-bp sequence followed by the 3' tail of the type 2 clone, suggesting an unspliced message (Fig 1A) . These data suggest that the type 3 cDNA corresponds to an unprocessed precursor that gives rise to the type 1 and 2 messages via alternative polyadenylation and splicing; when polyadenylation occurs at the most 5' site, the type 1 message is exclusively produced, whereas downstream polyadenylation allows in frame splicing of the type 2 tail to occur.
Primary structure of the EOS47 protein. The predicted amino acid sequence for EOS47 type 1 clones is shown in Fig 1B. The 738 amino acid sequence shows striking homology to members of the transferrin supergene family. Highest homology (61.1% identity) was observed with human melanotransfemn, the only transfemn family member known to occur in a membrane-bound f~r m ?~,~~ This homology begins just after the putative 19 amino acid signal peptide and ends abruptly at the beginning of a carboxy-terminal stretch of 27, largely hydrophobic, amino acids (Fig l b and data not  shown) .
Despite their membrane localizations, both the human and avian proteins lack optimal transmembrane sequences due to proline and hydrophilic residues within the relatively hydrophobic C-terminal domain ( Fig 1B and Rose et a135). In addition, both proteins lack charged residues beyond this potential transmembrane stretch that could serve to anchor them on the cytoplasmic face of the endoplasmic reticulum, Golgi, and plasma membrane. In the case of human melanotransferrin, it has been shown that the hydrophobic tail is cleaved and a glycosyl-phosphatidylinositol anchor (GPI) is added cotranslationally or posttran~lationally.~~.~~ To test if EOS47 shares this posttranslational modification, HDlOO cells were stained for surface EOS47 and VLA-2 expression (a known transmembrane protein) before and after treatment with phosphoinositide-specific phospholipase C (PI-PLC), an enzyme that specifically cleaves GPI-linked tails from proteins.39 As shown in Fig 2, pretreatment of HDlOO with PI-PLC removes virtually all of the detectable EOS47 from the cell surface, whereas no change is observed for VLA-2 expression. This would indicate that EOS47 is also expressed as a GPI-linked molecule.
The carboxy-terminal tail encoded by type 2 clones is shown in Fig 1C. The alternative tail replaces the last 27 amino acids of the coding sequence with a 10 amino acid stretch of hydrophilic amino acids, suggesting that this message encodes a secreted form of the molecule (Fig 1C) .
Consistent with this observation, expression of the type 2 clone in insect cells using a baculovirus vector results in high level production of EOS47 in the culture supernatant (data not shown). Soluble forms of human melanotransferrin have also been detected previously in melanoma culture supernatants, but it was proposed that these were not the result of variable mRNA processing?'
Although the calculated molecular weight of EOS47 (80,912 Daltons) is significantly less than the 1 0 0 -k D apparent molecular weight observed for the antigen purified from avian eosinophils,'* this discrepancy may be accounted for by glycosylation at one of the six potential N-linked glycosylation sites (one of which is shared with human melanotransferrin). The protein contains 28 cysteine residues, all of which are perfectly conserved with melanotransfemn, sug- 
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gesting a similar overall tertiary structure (Fig 3) . Like melanotransfenin, EOS47 contains two repeated domains that, by analogy with other vertebrate transfenin family members, should correspond to two independent iron-binding domains (Fig 1B and 3A) . Structural analysis of vertebrate transfemns indicates that four amino acids in each repeat are crucial ligands for coordinating iron, Asp-60, Tyr-92, Tyr-193, and His-253 (using the human lactofenin numbering system), and that an additional Arg residue at position 143 is required for binding of a CO:-anion (Fig 3A and B) .36 Human mela- notransferrin has only one functional iron-binding domain per molecule, presumably due to a point mutation of Asp to Ser in the carboxy-terminal iron-binding domain and mutation of Arg to Serin the anion binding site (Fig 3B) ." EOS47 contains a similar point mutation of Asp to Gly in the carboxy-terminal iron binding site and an additional mutation of His to Glu within the same domain (Fig 3B) . This second mutation is a relatively conservative substitution and, although it has never been observed in any vertebrate transferrin, it is present in the amino-terminal domain of two use only. insect transferrins which have retained the ability to bind iron ( Fig 3B) .4'342 In the amino-terminal domain of EOS47, there is a nonconservative mutation of the neutral His to positively charged Arg that should ablate the ability of this position to coordinate iron (Fig 3B) . The data therefore suggest that the amino-terminal domain of EOS47 may also have a lower affinity for iron or that the protein may have evolved a completely novel ligand specificity.
Computer alignment of the primary amino acid sequence of EOS47 with 11 transferrin family members from various species and construction of an evolutionary tree for transferrin family members shows a distinct segregation of human melanotransferrin and EOS47 (Fig 4) . This cosegregation of EOS47 and human melanotransfenin suggests again that EOS47 represents the avian homologue of the human protein and that the divergence of melanotransferrins from serum transferrins and lactofemns occurred before the divergence of birds from mammals. This also indicates that melanotransfenin is highly conserved during evolution and probably exerts an indispensable function in higher vertebrates.
Relative Fluorescence Intenstty (log)
Expression pattern of EOS47 mRNA and protein in cell lines and tissues. EOS47 mRNA expression was analyzed in a number of hematopoietic cell lines. A major transcript of 2.8 kb and a minor transcript of 3.5 kb were observed in the antigen-positive cell lines HDl OO and HLXOM-GATAl + (an eosinophil cell line recently produced in our lab'*) but not in antigen-negative B-, T-, myeloid, erythroid, or progenitor cell lines (Fig 5A) . Similar sized bands were detected with type l and type 2 specific probes, although the type 2 probe yielded considerably weaker hybridization with the 2.8-kb band (data not shown). These results suggest that the 3.5-kb transcript corresponds to the unspliced type 3 clone that contains untranslated regions detected by both type 1 and type 2 probes (Fig 1A) .
Analysis of RNA from tissues of 2-day-old and 5-weekold chickens showed transcripts in intestine, liver, and kidney, but not in bone marrow, brain, bursa of Fabricius (the primary site of B lymphopoiesis in birds), eye, Harderian gland (an ocular associated tissue rich in plasma cells in birds), heart, muscle, and spleen (Fig 5B) . The lack of detect- able expression in bone marrow and spleen probably reflects the low frequency of antigen positive eosinophils in these tissues (see below). Although expression of human melanotransferrin in liver and embryonic intestine has been reported previously, expression in kidney has not been o b~e r v e d .~~.~~.~
To further delineate the cell types expressing EOS47 in kidney, intestine, and liver, protein expression was analyzed by immunohistology of frozen tissue sections (Fig 5C) . In intestine, EOS47 protein is expressed at high levels on the apical face of epithelial cells on the brush borders of the villi. In young animals (5 days posthatching), the staining is most prominent in the crypts, suggesting an association with immature enterocytes, but in older animals the antigen is uniformly expressed throughout the length of the villi, suggesting expression throughout enterocyte maturation ( Fig  5C) . In kidney, EOS47 is also expressed by brush borders in the thick-walled proximal tubules and is absent on glomeruli, distal tubules, and collecting tubules. EOS47 is also weakly expressed by sinusoid endothelial cells in the liver (Fig 5C) .
We previously reported the expression of EOS47 by a small percentage (2% to 4%) of peroxidase+ and peroxidasecells in bone marrow and spleen." These results were confirmed in experiments in which bone marrow was separated into EOS47+ and EOS47-fractions by fluorescence-activated cell sorting and these fractions were assessed for the frequency of eosinophils by staining for eosinophil peroxidase. The results obtained from one of three such experiments are shown in Fig 6A and B. From a starting population of 1.3% EOS47+ bone marrow cells, one round of sorting resulted in a population which was 3 1.1 % EOS47+ and these were then resorted to greater than 70% positive. The percentage of peroxidase+ eosinophils was dramatically increased in all EOS47-enriched fractions, from 0.9% in unsorted bone marrow to 15.9% after the first round of sorting and to 34.9% after the second round. Control sorts were performed in parallel using nonspecific isotype-matched control antibody or the MYL51/2 antibody that is weakly expressed by avian myeloblast^.^^ In both cases these sorts resulted in a depletion rather than an enrichment of eosinophils (data not shown), confirming that the purification of eosinophils using EOS47 antibody is not due to nonspecific binding of mouse IgG.
Despite the increase in eosinophils in EOS47-enriched bone marrow, a small percentage of eosinophils was still detectable in EOS47-depleted fractions, suggesting that not all bone marrow eosinophils express the antigen. This observation was confirmed in experiments in which eosinophils were enriched by Percoll density fractionation and subsequently stained for EOS47 expression (Fig 6C and D) . Bone marrow eosinophils tended to sediment in density fractions from 1.06 to 1.09 g/mL, whereas peripheral blood eosinophils banded in fractions from 1.09 to 1.11 g/mL. In the high-density fractions from bone marrow, the frequency of EOS47+ cells exceeded that of peroxidase' cells. Because E26-transformed progenitors undergoing eosinophil differentiation in vitro usually express EOS47 before peroxidase, these cells may represent committed eosinophil precursors that have not yet acquired peroxidase However, consistent with the cell sorting experiments, several fractions contained more peroxidase+ cells than EOS47+ cells, indicating that a small proportion of mature eosinophils lack expression of the antigen (Fig 6C and D) . In fact, none of the peripheral blood fractions enriched for peroxidase+ eosinophils contained significant numbers of EOS47' cells (>OS%, see Fig 6D) . Similar results were obtained from both young (8 day) and juvenile (5 week) chickens (data not shown). This suggests that, before or soon after leaving the bone marrow, eosinophils lose expression of the antigen.
DISCUSSION
In this study, we have cloned and analyzed several cDNAs encoding the eosinophil-specific protein EOS47 and further characterized its distribution on normal avian cells. The following observations suggest that the EOS47 antigen is the avian homologue of human melanotransferrin. First, the proteins exhibit 6 1 % sequence identity, including conservation of all 28 cysteine residues (many of which are not conserved with lactoferrin or serum transferrin), indicating similar protein folding and tertiary ~tructure.~' Second, of the known transferrin supergene family members, only EOS47 and human melanotransferrin occur predominantly in membranebound forms and in both cases this is due to posttranslational or cotranslational addition of a GP1 anchor, a relatively uncommon posttranslational modifi~ation.~',~~ Expression of low levels of soluble melanotransferrin has also been reported for human melanoma cells, but whether these arise due to RNA processing or posttranslational processing has not been resolved.37 Our data would indicate that, in birds, expression of a soluble form of the molecule may in fact be regulated at the level of alternative polyadenyiation and premRNA splicing. Such a mechanism has previously been shown to govern the production of secreted versus transmembrane Ig heavy chain in which there is a switch in the efficiency of cleavage and polyadenylation during the maturation of B cells into plasma
In addition to their shared biochemical and structural properties, EOS47 and human melanotransferrin also show an overlapping distribution in nonhematopoietic tissues, imuse only. use only.
For personal at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From plying conservation of function. Thus, both proteins are expressed on the brush border linings of intestinal epithelial cells and on the apical surface of sinusoidal cells in the has a broader pattern of expression because it is expressed by intestinal epithelia in juvenile birds long after hatching, whereas in humans melanotransferrin has been reported to be fetal intestine-specifi~.~~~~~~~ It also remains to be determined whether human melanotransferrin, like EOS47, is expressed by early eosinophils and by brush border cells of the proximal tubules in kidney.
In previous experiments, we have shown that in vitro differentiation of hematopoietic precursor cell lines results in high level expression of this antigen by eosinophilic precursors just before the expression of eosinophil peroxidase and that the expression then gradually decreases as these cells mature and terminally differentiate.l2.I3 In the present studies, we have shown a corresponding distribution on normal eosinophils and expression by eosinophils and presumptive precursors in bone marrow but not by circulating eosinophils in peripheral blood. Although several molecules have been described to be specifically expressed in eosinophilic granules (such as eosinophil peroxidase, eosinophil cationic protein, major basic protein, and eosinophil-derived neurot~x i n ) ,~ to our knowledge this is the first description of an eosinophil-specific membrane protein in any species. Thus, EOS47/melanotransferrin should be a valuable reagent for the isolation and study of eosinophil precursors, particularly if a similar expression pattern is found on mammalian eosinophils. In this regard, it will be of interest to see if melanotransferrin is also a marker of newly formed mammalian eosinophils and their precursors (manuscript in progress). Because these cells comprise a very minor subpopulation of total bone marrow cells, the expression of melanotransferrin in mammals could easily have been overlooked in previous studies.
The reported tumor-specific nature of the human melanotransferrin protein, the observation that melanoma patients can develop an antibody response against this antigen, and the finding that a recombinant vaccinia virus expressing melanotransferrin can generate a T-cell response and protective immunity to melanoma cells in mice have led to the promotion of this protein as a potential target for immunotherapy of melan~ma!~-~' Yet, despite the attention this molecule has attracted in tumor models, relatively little is known about its function. Because all rapidly proliferating cells require iron for ribonucleotide reductase and other enzymes essential to cell division, it has been proposed that melanotransfemn acts as an alternative iron adsorption mechanism to the classic transferridtransfenin receptor mediated pathway and thereby augments the proliferation of tumor ~e l l s .~~~~' However, studies performed to address this hypothesis have yielded inconclusive or even conflicting r e s~l t s ,~~*~~ and several lines of evidence suggest that high affinity iron-binding might not be the primary function of the molecule. First, human melanotransferrin has acquired point mutations that inactivate one iron-binding domain and thereby lower the molecule's overall avidity for iron and reduce its efficiency as an iron transporter.@ Similarly, the avian molecule has liver.38.43.44 However, our results also suggest that EOS47 acquired deleterious mutations in both iron-binding pockets, which suggests that it has evolved away from high-affinity iron-binding. Second, growth of HDlOO cells in the presence of iron-chelating agents or hemin has no effect on the level of the avian melanotransferrin expression, whereas these agents have been shown to have profound effects on the expression of a number of molecules involved in iron uptake and storages4 (unpublished observations). Similarly, despite the proposal that melanotransfemn bypasses the transferrin receptor pathway for iron uptake, neither avian nor human RNAs for melanotransfenin contain iron-responsive elements (IRES), which have proved to be the key regulators of transferrin receptor expre~sion.'~ Lastly, the high level expression of the antigen in the proximal tubules of kidney also argues against this idea. Under normal circumstances, free iron never reaches the proximal tubules in kidney because it remains bound to transferrin that is retained in the glomerulus during blood filtration. Thus, this distribution does not correlate with an iron binding function.
What then is the primary function of melanotransferrin? An intriguing possibility is suggested by the recent cloning and analysis of another transferrin-like protein known as saxion the basis of its ability to specifically bind saxitoxin, a low molecular weight neurotoxin. Although saxiphilin displays a high overall homology to serum transfemns, it lacks all but one of the known iron-ligating amino acids and has probably evolved a novel specificity for exogenously or endogenously produced toxins.56 Thus, there is a precedence for novel ligand specificities in transferrin-like molecules. By analogy, melanotransferrin may have evolved to bind and inactivate toxic substances present in intestine or generated during kidney filtration or eosinophil maturation. Further experiments are required to elucidate the molecule's true function.
Because of its restricted distribution within the hematopoietic system to early eosinophils, analysis of the regulatory elements that govern the expression of melanotransferrin may provide insights into mechanisms governing eosinophilspecific gene expression. Recently, we have shown that the overexpression of the GATA-1 transcription factor in avian myelomonocytic cells is sufficient to convert these cells into eosinophils." Similarly, overexpression of the CEBPP transcription factor (NF-IL-6 or NF-M) in multipotent hematopoietic precursors results in eosinophilic differentiati~n.~~ In these experiments, the expression of EOS47 represented one of the first detectable phenotypic changes, suggesting that the gene is a direct target of GATA-1, CEBPP, and perhaps additional transcription factors. It is noteworthy that GATA-1 and CEBPP are coexpressed in eosinophils, although they are expressed individually in a number of other hematopoietic lineage^.'^^^^^^^ This suggests that a combinatorial effect of these factors may be required for eosinophilic differentiat i~n . ' * . ~~ We are presently analyzing the EOS47 promoter in an attempt to define how these and other factors influence eosinophil differentiation. 
